|
WO2011150939A1
(en)
|
2010-06-01 |
2011-12-08 |
Glycom A/S |
Polymorphs of 2'-o-fucosyllactose and producing thereof
|
|
AU2011278236A1
(en)
*
|
2010-07-16 |
2013-02-07 |
Glycom A/S |
Derivatization of oligosaccharides
|
|
DK2658399T4
(da)
|
2010-12-31 |
2024-03-25 |
Abbott Lab |
Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
|
|
MY191538A
(en)
|
2010-12-31 |
2022-06-30 |
Abbott Lab |
Human milk oligosaccharides to promote growth of beneficial bacteria
|
|
BR112013016606A2
(pt)
|
2010-12-31 |
2016-09-27 |
Abbott Lab |
processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
|
|
CA2822219C
(en)
|
2010-12-31 |
2020-12-29 |
Abbott Laboratories |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
|
|
MY196432A
(en)
|
2010-12-31 |
2023-04-10 |
Abbott Lab |
Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
|
|
BR112013016903A2
(pt)
|
2010-12-31 |
2019-09-24 |
Abbott Lab |
oligossacarídeos de leite humano para modular inflamação
|
|
BR112013016587A2
(pt)
|
2010-12-31 |
2016-09-27 |
Abbott Lab |
formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
|
|
WO2012113404A1
(en)
*
|
2011-02-21 |
2012-08-30 |
Glycom A/S |
Novel glycosyl phosphites
|
|
CN103443113A
(zh)
*
|
2011-03-18 |
2013-12-11 |
格力康公司 |
新型含岩藻糖的糖类衍生物的合成
|
|
EP2522232A1
(en)
*
|
2011-05-13 |
2012-11-14 |
Nestec S.A. |
Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
|
|
WO2012155916A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Glycom A/S |
Manufacture of lacto-n-tetraose
|
|
HK1199607A1
(en)
|
2011-08-29 |
2015-07-10 |
Abbott Laboratories |
Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
|
|
EP2760875A4
(en)
*
|
2011-09-30 |
2015-08-26 |
Glycom As |
SYNTHESIS OF HMO NUCLEAR STRUCTURES
|
|
ES2601891T3
(es)
|
2011-10-18 |
2017-02-16 |
Nestec S.A. |
Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor
|
|
WO2013091660A1
(en)
*
|
2011-12-23 |
2013-06-27 |
Glycom A/S |
A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
|
|
DE202013012829U1
(de)
|
2012-06-14 |
2020-03-04 |
Glycom A/S |
Verbesserung der Stabilität und Reinheit sowie Erhöhung der Bioverfügbarkeit von menschlichen Milch-Oligosacchariden oder Vorläufern oder Mischungen davon
|
|
ITFI20120143A1
(it)
|
2012-07-12 |
2014-01-13 |
Inalco S A S Di Giovanni Cipollett I & C |
Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
|
|
ES2572831T3
(es)
|
2012-09-14 |
2016-06-02 |
Abbott Laboratories |
Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
|
|
DK2708147T3
(da)
*
|
2012-09-14 |
2020-05-18 |
Abbott Lab |
Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
|
|
EP2943500B1
(en)
*
|
2012-11-13 |
2017-11-08 |
Glycom A/S |
Crystalline 3-o-fucosyllactose
|
|
DK2999358T3
(en)
|
2013-05-22 |
2021-10-11 |
Glycom As |
Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
|
|
CN103408609B
(zh)
*
|
2013-09-02 |
2016-01-13 |
济南尚博生物科技有限公司 |
一种制备1-S-2,3,4-三-O-苄基-l-硫代吡喃岩藻糖苷的方法
|
|
DK3041946T4
(en)
|
2013-09-06 |
2025-11-03 |
Glycom As |
Fermentative production of oligosaccharides
|
|
EP2857410A1
(en)
*
|
2013-10-04 |
2015-04-08 |
Jennewein Biotechnologie GmbH |
Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
|
|
EP2896628B1
(en)
*
|
2014-01-20 |
2018-09-19 |
Jennewein Biotechnologie GmbH |
Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
|
|
CN104098615A
(zh)
*
|
2014-06-09 |
2014-10-15 |
华中科技大学 |
一种以氢氧根离子型的碱为催化剂进行脱酰基化的方法
|
|
CN106795193B
(zh)
|
2014-09-12 |
2021-02-26 |
巴斯夫欧洲公司 |
制备2′-o-岩藻糖基乳糖的方法
|
|
PL3209673T5
(pl)
|
2014-10-24 |
2023-10-23 |
Glycom A/S |
Mieszaniny hmo
|
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
EP3212197A4
(en)
|
2014-10-29 |
2018-07-11 |
Glycom A/S |
Synthetic composition and method for treating irritable bowel syndrome
|
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
EP3212198B1
(en)
|
2014-10-29 |
2020-12-23 |
Glycom A/S |
Synthetic composition and method for promoting mucosal healing
|
|
US10500221B2
(en)
|
2014-12-05 |
2019-12-10 |
Glycom A/S |
Crystalline difucosyllactose
|
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
EP3229812A4
(en)
|
2014-12-08 |
2018-10-03 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
|
CN107405354A
(zh)
|
2015-03-05 |
2017-11-28 |
格礼卡姆股份公司 |
治疗急性呼吸道感染的组合物和方法
|
|
WO2016157108A1
(en)
|
2015-03-31 |
2016-10-06 |
Glycom A/S |
Mixtures of human milk oligosaccharides comprising 3 '-o-sialyllactose
|
|
CN107614511B
(zh)
|
2015-06-09 |
2020-10-23 |
格礼卡姆股份公司 |
6’-SL、LNnT和LST c的三元混合物
|
|
RU2634707C2
(ru)
*
|
2015-07-23 |
2017-11-03 |
Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства |
Способ избирательного удаления О-ацетильных защитных групп в присутствии О-бензоильных
|
|
ES2886951T3
(es)
|
2015-09-14 |
2021-12-21 |
Glycom As |
Composición para su uso en la modulación de la microbiota
|
|
US10780103B2
(en)
|
2015-10-28 |
2020-09-22 |
Glycom A/S |
Synthetic composition and method for modulating emotion and mood disorders
|
|
PL3368046T3
(pl)
|
2015-10-28 |
2022-11-28 |
Glycom A/S |
Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
|
|
EP3377071B1
(en)
|
2015-11-17 |
2024-01-10 |
Glycom A/S |
Human milk oligosaccharides for treating antibiotic associated complications
|
|
EP3389668A4
(en)
|
2015-12-15 |
2019-08-21 |
Glycom A/S |
MIXTURE OF HMOS
|
|
MX2018009515A
(es)
*
|
2016-02-03 |
2018-09-05 |
Basf Se |
Proceso para producir 2'-o-fucosil lactosa.
|
|
WO2017144062A1
(en)
|
2016-02-24 |
2017-08-31 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
JP2019509285A
(ja)
*
|
2016-03-09 |
2019-04-04 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
2’−o−フコシルラクトースの製造方法
|
|
KR101731263B1
(ko)
|
2016-04-25 |
2017-05-02 |
서울대학교 산학협력단 |
코리네박테리움 글루타미쿰을 이용한 2'-푸코실락토오스의 생산방법
|
|
ES2924137T3
(es)
|
2016-05-05 |
2022-10-04 |
Glycom As |
Composición que comprende HMOS para uso en el tratamiento de la hipersensibilidad y/o dolor visceral mediados por mastocitos
|
|
DK3452050T3
(da)
|
2016-05-05 |
2023-02-20 |
Glycom As |
Composition comprising hmos for the treatment of noninfectious diarrhoea
|
|
CN105924480B
(zh)
*
|
2016-05-10 |
2018-09-25 |
浙江大学 |
含岩藻糖三糖硫酸酯及其制备方法和应用
|
|
US11224605B2
(en)
|
2016-05-19 |
2022-01-18 |
Glycom A/S |
Synthetic composition
|
|
EP3474861A4
(en)
|
2016-06-24 |
2020-04-15 |
Glycom A/S |
COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
|
|
WO2018157900A1
(en)
|
2017-03-01 |
2018-09-07 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
EP3634429A4
(en)
|
2017-05-09 |
2020-11-04 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
|
WO2018215960A1
(en)
|
2017-05-24 |
2018-11-29 |
Glycom A/S |
Synthetic composition comprising one or more human milk oligosaccharides (hmos)
|
|
WO2018215961A1
(en)
|
2017-05-24 |
2018-11-29 |
Glycom A/S |
Synthetic composition comprising oligosaccharides and its use in medical treatment.
|
|
US11524019B2
(en)
|
2017-08-21 |
2022-12-13 |
Glycom A/S |
Synthetic composition for reducing allergy symptoms
|
|
EP3450443A1
(en)
|
2017-08-29 |
2019-03-06 |
Jennewein Biotechnologie GmbH |
Process for purifying sialylated oligosaccharides
|
|
CN111356461A
(zh)
|
2017-10-04 |
2020-06-30 |
加利福尼亚大学董事会 |
免疫调节性低聚糖
|
|
CN111526879A
(zh)
|
2017-11-02 |
2020-08-11 |
格礼卡姆股份公司 |
用于减少或预防疲劳和/或改善注意力或专注力的一种或多种hmo
|
|
EP3716984B1
(en)
|
2017-11-30 |
2024-03-20 |
Glycom A/S |
Mixture of hmos for treating wheat sensitivity
|
|
US11602545B2
(en)
|
2017-12-05 |
2023-03-14 |
Glycom A/S |
Human milk oligosaccharides for treating migraine
|
|
WO2019123316A1
(en)
|
2017-12-22 |
2019-06-27 |
Glycom A/S |
Composition comprising hmos for preventing or reducing nociception
|
|
CN108084234A
(zh)
*
|
2018-01-23 |
2018-05-29 |
佛山科学技术学院 |
双重随机糖基化合成三糖的方法
|
|
US11554131B2
(en)
|
2018-05-31 |
2023-01-17 |
Glycom A/S |
Mixture of HMOs for treating autoimmune diseases
|
|
AU2019362595B2
(en)
|
2018-10-18 |
2024-12-19 |
Basf Se |
Crystalline form II of 2'-O-fucosyllactose, process for its preparation, nutritional, cosmetic or pharmaceutical formulation containing the same
|
|
CN113194960A
(zh)
|
2018-12-19 |
2021-07-30 |
格礼卡姆股份公司 |
用于治疗使用低fodmap饮食的人的组合物和方法
|
|
EP3741770A1
(en)
|
2019-05-21 |
2020-11-25 |
Jennewein Biotechnologie GmbH |
Purification of oligosaccharides from a fermentation broth by using filtration
|
|
EP4065128A4
(en)
|
2019-11-29 |
2023-12-20 |
Glycom A/S |
MIXTURE OF HMOS TO IMPROVE THE MICROBIOTA OF PREGNANT WOMEN
|
|
CN115279778B
(zh)
|
2020-03-12 |
2025-06-24 |
格礼卡姆股份公司 |
2’-fl的结晶
|
|
CN111588726A
(zh)
*
|
2020-04-28 |
2020-08-28 |
南开大学 |
2′-岩藻糖基乳糖调节宿主肠道菌群及增强肠屏障的应用
|
|
EP4255444A4
(en)
|
2020-12-04 |
2024-10-16 |
Glycom A/S |
Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
|
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
|
WO2023099297A1
(en)
*
|
2021-12-02 |
2023-06-08 |
Dsm Ip Assets B.V. |
Synthesis of hmo butyrate
|
|
WO2024013393A1
(en)
|
2022-07-15 |
2024-01-18 |
Dsm Ip Assets B.V. |
Combination of bifidobacterium and fucosylated hmo for use in increasing nmn or nad+
|
|
EP4619409A1
(en)
*
|
2022-11-15 |
2025-09-24 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for preparing an at least partially acetal-protected sugar
|
|
WO2025196273A1
(en)
|
2024-03-22 |
2025-09-25 |
Dsm Ip Assets B.V. |
Combination of mixtures of hmos with mfgm and their use
|
|
WO2025196272A1
(en)
|
2024-03-22 |
2025-09-25 |
Dsm Ip Assets B.V. |
Combination of mixtures of hmos with mfgm and their use
|
|
WO2025219496A1
(en)
|
2024-04-19 |
2025-10-23 |
Dsm Ip Assets B.V. |
Nutritional composition comprising bifidobacterium longum ssp. infantis r0033 and human milk oligosaccharides
|
|
WO2025219497A1
(en)
|
2024-04-19 |
2025-10-23 |
Dsm Ip Assets B.V. |
Combination comprising bifidobacterium bifidum ha-132 and human milk oligosaccharides
|
|
WO2025219495A1
(en)
|
2024-04-19 |
2025-10-23 |
Dsm Ip Assets B.V. |
A nutritional composition comprising bifidobacterium bifidum r0071 and human milk oligosaccharides
|